PUMP-2 published in JCO! HAIP chemo for intrahepatic cholangiocarcinoma #pump #CCA @FlavioRochaMD @ArndtVogel @curecc @timpawlik @DrAngelaLamarca @LorenzaRimassa @SyedAAhmad5 @JCO_ASCO https://t.co/vG6tVXEoQ8

Should we incorporate #HAIP into our arsenal of management for iCCA? Read this study by ⁦@BasGrootKoerkam⁩ … PUMP-2 Trial | ⁦@JCO_ASCO⁩

The #SSO2026 Program Committee is excited to announce that the 2026 Annual Meeting preliminary program is now live! Learn more and register now: https://t.co/1vKfxGPzSY

Finding somatic mutations in healthy tissue that can lead to cancer, at scale. Yet another path to primary prevention https://t.co/f4RnBCgZQ2 https://t.co/zbHztHzZLh

Do you have #PancreaticCancer with a BRCA1, BRCA2, or PALB2 mutation and resected (surgically removed) pancreatic cancer? If so, you may be able to participate in this study of a potential new treatment. Learn more: https://t.co/SjQfzYADSW cc: @KReissMD

Congratulations to @MPettigrewMD of @UTSWSurgeryLife on completing her @AmCollSurgeons Resident Research scholarship! She did a great job summarizing our work on molecular mechanisms behind gastric cancer immune evasion. @UTSW_Surgery @utswcancer

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage https://t.co/pWwExgNItL

🧬 Today is National Previvor Day 💙 A day to understand and honor those who take proactive steps to understand and manage inherited cancer risk. 🎨 The image we’re sharing is by Mark A. Hicks. Learn more about him and his work here 👉 https://t.co/MJh2y3TVrI 👩‍⚕️ Our members

We are pleased to announce that Dan G. "Trey" Blazer, III, MD, Professor of Surgery, has been named Interim Chief of the Division of Surgical Oncology (@DukeSurgOnc). Read more: https://t.co/g97nSYxn6Q @DukeMedSchool

Last week, we welcomed our new faculty to the Department of Surgery with a Welcome Cake Reception! This was a great opportunity for our new folks to have time to meet the faculty while enjoying a sweet treat. Welcome Drs. Bai, Jolissaint, and Shah!

If you're a Surgical Oncologist, read this: From @AdamYopp and colleagues, they suggest it is time to re-evaluate the current #CGSO training paradigm vis-a-vis research time during residency. Well-written and a MUST read. 👀 https://t.co/MHLduWe4D0 @SocSurgOnc @AnnSurgOncol

Do you know? 🧬 Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function ... Great work by colleagues @COliveiraLabi3S and @SilvanaLobo21. Happy to have contributed. #HDGC #StomachCancer

We are thrilled to share our latest results on the impact of #CTNNA1 germline variants in #HDGC, just published in #GUT! We report a significant risk of developing diffuse gastric in carriers of loss-of-function CTNNA1 germline variants carriers. ➡️🔗 https://t.co/JUPugGE4I4

Trump administration to appoint @DanaFarber oncologist @DrTonyLetai to run National Cancer Institute (@theNCI) https://t.co/rbRLCOovTQ

📢Our prelude to Hereditary Cancer Awareness Week continues with the 🌟 Patient Perspective 🌟 previews. Today we’re honored to share a highlight from Gwen Ottinger’s story 💙 In her reflections, Gwen shares what she hopes others will take away from her experience. She speaks

Early national data from nearly 1,300 facilities show variable compliance (53–88%) with new ACS operative standards, underscoring the need for stronger quality improvement in cancer surgery. https://t.co/az2mlW8UpP

Did you know that gastric polyposis caused by an APC promoter mutation increases the risk of #StomachCancer? Check out our new paper, authored by @ShruthiPeratiMD https://t.co/BQQzTZMK4P #GAPPS @SocSurgOnc @AnnSurgOncol @StomachCancer_ @NoStomach4Cancr

We’re excited to announce that registration for the #SSO2026 Annual Meeting is officially open! 🎉Join us March 5–7, 2026, in Phoenix, Arizona, for an enriching experience filled with education, networking, and much more. Secure your spot: https://t.co/rnnG1jhYbV

South Florida has beaten No. 25 Boise State in Week 1 AND No. 13 Florida in Week 2 👀 Since the preseason AP poll debuted in 1950, only 4 schools have started 3-0 with all 3 wins against ranked opponents. Can they secure the win against No. 5 Miami in Week 3 🤔

"#Colorectalcancer (#CRC) disproportionately affects #Black individuals...who experience higher #incidence & #mortality, & lower #survival rates than White individuals..." "...no #Black–#White differences exist in the prevalence of [PGVs in] high penetrance #germline #CRC or